[HTML][HTML] Network medicine in the age of biomedical big data
Network medicine is an emerging area of research dealing with molecular and genetic
interactions, network biomarkers of disease, and therapeutic target discovery. Large-scale …
interactions, network biomarkers of disease, and therapeutic target discovery. Large-scale …
Emerging role of SOX proteins in breast cancer development and maintenance
The SOX genes encode a family of more than 20 transcription factors that are critical
regulators of embryogenesis and developmental processes and, when aberrantly …
regulators of embryogenesis and developmental processes and, when aberrantly …
[HTML][HTML] Are transcription factors plausible oncotargets for triple negative breast cancers?
M Marqués, MA Sorolla, I Urdanibia, E Parisi, I Hidalgo… - Cancers, 2022 - mdpi.com
Simple Summary Triple negative breast cancer is a type of breast cancer that does not have
a selective and effective therapy. It is known that this cancer possesses high abundance of …
a selective and effective therapy. It is known that this cancer possesses high abundance of …
STAT3 and GR cooperate to drive gene expression and growth of basal-like triple-negative breast cancer
ME Conway, JM McDaniel, JM Graham, KP Guillen… - Cancer research, 2020 - AACR
Breast cancers are divided into subtypes with different prognoses and treatment responses
based on global differences in gene expression. Luminal breast cancer gene expression …
based on global differences in gene expression. Luminal breast cancer gene expression …
[HTML][HTML] Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate Cancer
PM Schnepp, A Ahmed, J Escara-Wilke, J Dai… - BMC cancer, 2021 - Springer
Background Overcoming drug resistance is critical for increasing the survival rate of prostate
cancer (PCa). Docetaxel is the first cytotoxic chemotherapeutical approved for treatment of …
cancer (PCa). Docetaxel is the first cytotoxic chemotherapeutical approved for treatment of …
[HTML][HTML] Identification and functional analysis of SOX10 phosphorylation sites in melanoma
JC Cronin, SK Loftus, LL Baxter, S Swatkoski… - PLoS …, 2018 - journals.plos.org
The transcription factor SOX10 plays an important role in vertebrate neural crest
development, including the establishment and maintenance of the melanocyte lineage …
development, including the establishment and maintenance of the melanocyte lineage …
[HTML][HTML] AKT-mediated phosphorylation of Sox9 induces Sox10 transcription in a murine model of HER2-positive breast cancer
KN Al-Zahrani, J Abou-Hamad, J Pascoal… - Breast Cancer …, 2021 - Springer
Abstract Background Approximately 5–10% of HER2-positive breast cancers can be defined
by low expression of the Ste20-like kinase, SLK, and high expression of SOX10. Our lab has …
by low expression of the Ste20-like kinase, SLK, and high expression of SOX10. Our lab has …
[HTML][HTML] Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer
B Cao, Y Zhao, Z Zhang, H Li… - International …, 2018 - spandidos-publications.com
Lauren classification is a pathology-based gastric cancer (GC) subtyping system, which is
widely used in the clinical treatment of patients with GC. However, genome-scale molecular …
widely used in the clinical treatment of patients with GC. However, genome-scale molecular …
[HTML][HTML] Gnas Promoter Hypermethylation in the Basolateral Amygdala Regulates Reconsolidation of Morphine Reward Memory in Rats
P Liu, J Liang, F Jiang, W Cai, F Shen, J Liang, J Zhang… - Genes, 2022 - mdpi.com
Impairing reconsolidation may disrupt drug memories to prevent relapse, meanwhile long-
term transcription regulations in the brain regions contribute to the occurrence of emotional …
term transcription regulations in the brain regions contribute to the occurrence of emotional …
[HTML][HTML] Evaluation of early post-natal pig mammary gland development and human breast cancer gene expression
S Smith, A Stone, H Oswalt, L Vaughan, F Ferdous… - Developmental …, 2022 - Elsevier
Breast cancer is the second leading cause of death in women after lung cancer, and only
5% of patients with metastatic breast cancer survive beyond ten years of diagnosis …
5% of patients with metastatic breast cancer survive beyond ten years of diagnosis …